NMPA Approval

Bendamustine Hydrochloride for Injection

Approval Number

H20180087

Registration Date

December 17, 2018

Drug Information

Generic Name

注射用盐酸苯达莫司汀

Trade Name

存达

Dosage Form

注射剂

Strength

100mg(以C16H21Cl2N3O2·HCl计)

Drug Type

化学药品

Registration Date

December 17, 2018

Expiry Date

December 16, 2023

Company Address

145 Brandywine Parkway, W Chester, PA 19380，United States of America

Company Address

Swensweg 5, Haarlem 2031 GA Netherlands

Empowering clinical research with data-driven insights and AI-powered tools.

注射用盐酸苯达莫司汀 - NMPA 批准文号 | MedPath